Adverum Biotechnologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Adverum Biotechnologies Inc in the third quarter 2025?
Adverum Biotechnologies Inc recorded a cumulative net loss of $-204 million during 12 months ending in the third quarter 2025, resulting in a negative return on equity (ROE) of -3844.85%.

Within the Biotechnology & Pharmaceuticals industry 115 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 3009 to 4019.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Equity Change	-	-	-83.86 %	5.19 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-204	-189	-170	-151	-114
Return On Equity (TTM)	-3844.85 %	-408.43 %	-198.83 %	-125.42 %	-95.44 %
ADVM's Total Ranking	# 4019	# 3009	# 3326	# 0	# 3141
Equity (TTM) in Millions	-56	-20	26	71	108
Seq. Equity Change	-	-	-62.64 %	-34.69 %	-21.2 %
Seq. Net Income Change	-	-	-	-	-

Back to ADVM Management Effectiveness >> ADVM's 5 Years Annual ROE >> Compare ADVM ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 116
Sector	# 800
Overall	# 4019

Return On Equity Statistics
High	Average	Low
17.52 %	-153.8 %	-3844.85 %
(Sep 30 2017)		(Sep 30 2025)

ADVM Annual Return On Equity	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020
Total Equity in Millions	71	83	182	316	434
Y / Y Equity Change	-15.28 %	-54.02 %	-42.59 %	-27.2 %	148.26 %
Net Income in Millions	-131	-117	-155	-146	-118
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-185.15 %	-140.37 %	-85.14 %	-46.03 %	-27.05 %

Back to ADVM Management Effectiveness >> ADVM's 5 Years Annual ROE >> Compare ADVM ROE to its Competitors

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ADVM's' Return on Equity at Yahoo Finance
ADVM's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ADVM's Competitors
Subscribers only: Roe for Adverum Biotechnologies Inc 's Suppliers
Subscribers only: Return On Equity for ADVM's Customers

Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector

ROE

Date modified: 2026-08-29T17:23:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.